CV Sciences Inc

OTCQB:CVSIUnited States

Nov 21, 2024

Show headlines and story abstract

• DJ CV Sciences to Acquire Extract Labs in $1.4M Deal, from 4:58PM ET on Thursday Nov 21, 2024 by Dow Jones

  4:58PM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: CVSI
  
  By Dean Seal
  
  CV Sciences has agreed to acquire fellow CBD products maker Extract Labs for $1 million in newly issued common stock and $400,000 in cash.
  
  The San Diego-based company said Thursday that the acquisition should grow its sales and client base.
  

• CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs, from 4:30PM ET on Thursday Nov 21, 2024 by PR Newswire

  4:30PM ET on Thursday Nov 21, 2024 by PR Newswire
  Companies Mentioned: CVSI

  CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced that it has entered into a definitive agreement (the "Purchase Agreement") to acquire Extract Labs, Inc. ("Extract Labs"), a leading manufacturer and distributor of premium cannabinoid products including gummies, topicals and tinctures. Extract Labs branded products are sold through a range of sales channels from B2B to B2C. Extract Labs has operational flexibility allowing low to large minimum order quantity ("MOQ") production runs, allowing for efficient use of capital and the ability to increase speed to market for new product development. Extract Labs is GMP-certified and FDA-registered. The acquisition is expected to create the opportunity to increase our sales to current and new clients. In addition, we intend to in-source production of certain of our key products.

• CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs, from 4:30PM ET on Thursday Nov 21, 2024 by Dow Jones

  4:30PM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: CVSI
  
  CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs
  
  PR Newswire
  
  SAN DIEGO, Nov. 21, 2024
  
  SAN DIEGO, Nov. 21, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced that it has entered into a definitive agreement (the "Purchase Agreement") to acquire Extract Labs, Inc. ("Extract Labs"), a leading manufacturer and distributor of premium cannabinoid products including gummies, topicals and tinctures. Extract Labs branded products are sold through a range of sales channels from B2B to B2C. Extract Labs has operational flexibility allowing low to large minimum order quantity ("MOQ") production runs, allowing for efficient use of capital and the ability to increase speed to market for new product development. Extract Labs is GMP-certified and FDA-registered. The acquisition is expected to create the opportunity to increase our sales to current and new clients. In addition, we intend to in-source production of certain of our key products.
  

• *DJ CV Sciences, Inc. Enters Into Definitive Agreement To Acquire Extract Labs >CVSI, from 4:30PM ET on Thursday Nov 21, 2024 by Dow Jones

  4:30PM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: CVSI